The present invention relates to polymeric membranes. In particular, the present invention relates to the use of membranes comprising polyvinyl alcohol in electrophoresis.

The present invention relates to polymeric membranes. In particular, the present invention relates to the use of membranes comprising polyvinyl alcohol in electrophoresis.

Electrophoretic separation devices and methods for using the same are provided. Aspects of the devices include a polymeric separation medium that includes a plurality of microwells. Also provided are methods, systems and kits in which the subject devices find use. The devices and methods find use in a variety of different electrophoretic separation applications.

Electrophoretic separation devices and methods for using the same are provided. Aspects of the devices include a polymeric separation medium that includes a plurality of microwells. Also provided are methods, systems and kits in which the subject devices find use. The devices and methods find use in a variety of different electrophoretic separation applications.

The invention regards the use of triiodothyronine sulfate, commonly named T.sub.3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T.sub.3), as such or in association with thyroxine (T.sub.4), and pharmaceutical formulations for oral administration thereof.

The invention regards the use of triiodothyronine sulfate, commonly named T.sub.3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T.sub.3), as such or in association with thyroxine (T.sub.4), and pharmaceutical formulations for oral administration thereof.

Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the bound complex to migrate toward the electrode with opposite charge of the bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the bound complex band and one or both of the migration pattern and the migration velocity.

Applicant discloses an anti-idiotypic antibody to MOR202, which when fused to human albumin, shifted the anti-body in IFE thus mitigating any potential interference of MOR202 with the M-protein clinical assessment.

Applicant discloses an anti-idiotypic antibody to MOR202, which when fused to human albumin, shifted the anti-body in IFE thus mitigating any potential interference of MOR202 with the M-protein clinical assessment.

Systems and apparatus for performing analysis of human biological samples are described. Collected biological samples are combined with a substance including nucleic acid complexes and the combined substance is processed using gel electrophoresis. An indication of a detected compound in the biological sample and/or a particular medical condition associated with the detected compound is output from the apparatus.